Pricing Log in Create free account

Galecto, Inc. (DMRA) vs KARDIGAN INC (KARD)

Galecto, Inc. and KARDIGAN INC are both Biotechnology companies. Galecto, Inc. and KARDIGAN INC are of similar size ($1.4B and $1.3B). KARDIGAN INC has negative trailing earnings, so its P/E is not meaningful; Galecto, Inc. trades at 24.7×. Across the 9 metrics below, Galecto, Inc. leads on 5 and KARDIGAN INC on 4.

Valuation

Metric DMRA KARD Biotechnology median
P/E 24.65 n/m 10.60
P/S n/m n/m 9.40
P/B 4.00 0.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.82 0.66
EV/Sales n/m n/m 9.02
Earnings yield 4.06% (95.11%) (32.88%)
Free cash flow yield (4.05%) (43.18%) (23.13%)

Profitability

Metric DMRA KARD Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.51%) 0.00% (51.96%)
Return on assets (27.08%) 0.00% (46.06%)
Return on invested capital 0.00% (908.80%) 0.00%

Growth

Metric DMRA KARD Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (730.84%) (68.79%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DMRA KARD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.80 8.72 4.97
Net debt to EBITDA 1.22 1.70 1.01

Dividend

Metric DMRA KARD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DMRA KARD Biotechnology median
Market cap 1.35b 1.30b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack